Abacavir And Lamivudine 33342-0440-07
- Manufacturer
- Macleods Pharmaceuticals Limited
- Dosage Form
- Tablet, Film Coated
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- December 20, 2024
- Listing Expires
- December 31, 2026
- Application
- ANDA212663
Need to source Abacavir And Lamivudine? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Abacavir Sulfate | 600 mg/1 |
| Lamivudine | 300 mg/1 |
Drug Class
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]Cytochrome P450 1A1 Inhibitors [MoA]
Selected Package
33342-0440-07Selected30 TABLET, FILM COATED in 1 BOTTLE (33342-440-07)
Other packages for this product(2)
5 BLISTER PACK in 1 CARTON (33342-440-14) / 6 TABLET, FILM COATED in 1 BLISTER PACK (33342-440-02)
10 BLISTER PACK in 1 CARTON (33342-440-98) / 6 TABLET, FILM COATED in 1 BLISTER PACK (33342-440-02)